STOCK TITAN

New survey: 1 in 3 women have not talked to their doctor about heart health, the #1 killer of women

Rhea-AI Impact
(No impact)
Rhea-AI Sentiment
(Neutral)
Tags
A new Medtronic survey reveals concerning gaps in women's heart health awareness. Despite cardiovascular disease being the #1 killer of women in the U.S., 56% of women have never discussed heart health with their mothers or family members. The survey found that 45% of women were more likely to discuss sensitive topics like politics or money before family heart health history. Notably, 94% of women are responsible for family health decisions, yet 60% struggle to prioritize their own health. Women face significant disparities in heart disease treatment, being 35% less likely to receive minimally invasive solutions for heart valve failure compared to men. The impact is particularly severe among women of color, with 43% of Hispanic women and 59% of Black women experiencing cardiovascular disease. In response, Medtronic launched the 'Letter to My Mother' campaign to encourage heart health conversations and awareness.

Un nuovo sondaggio di Medtronic evidenzia preoccupanti lacune nella consapevolezza della salute cardiaca delle donne. Nonostante le malattie cardiovascolari siano la prima causa di morte tra le donne negli Stati Uniti, il 56% delle donne non ha mai parlato di salute del cuore con le proprie madri o con altri membri della famiglia. Il sondaggio ha rilevato che il 45% delle donne tende a discutere argomenti delicati come politica o denaro prima di affrontare la storia familiare delle malattie cardiache. È importante sottolineare che si occupa delle decisioni sanitarie familiari, ma il 60% fatica a dare priorità alla propria salute. Le donne affrontano notevoli disparità nel trattamento delle malattie cardiache, essendo il 35% meno propense a ricevere soluzioni minimamente invasive per il malfunzionamento delle valvole cardiache rispetto agli uomini. L'impatto è particolarmente grave tra le donne di colore, con il 43% delle donne ispaniche e il 59% delle donne nere che soffrono di malattie cardiovascolari. In risposta, Medtronic ha lanciato la campagna 'Lettera a mia madre' per promuovere conversazioni e consapevolezza sulla salute del cuore.
Una nueva encuesta de Medtronic revela preocupantes brechas en la conciencia sobre la salud cardíaca de las mujeres. A pesar de que las enfermedades cardiovasculares son la principal causa de muerte entre las mujeres en EE. UU., el 56% de las mujeres nunca ha hablado sobre la salud del corazón con sus madres o familiares. La encuesta encontró que el 45% de las mujeres es más propenso a discutir temas delicados como política o dinero antes que el historial familiar de enfermedades cardíacas. Cabe destacar que el 94% de las mujeres se encargan de las decisiones de salud familiares, pero el 60% tiene dificultades para priorizar su propia salud. Las mujeres enfrentan disparidades significativas en el tratamiento de enfermedades cardíacas, siendo un 35% menos propensas a recibir soluciones mínimamente invasivas para la insuficiencia de la válvula cardíaca en comparación con los hombres. El impacto es especialmente grave entre las mujeres de color, con el 43% de las mujeres hispanas y el 59% de las mujeres negras que experimentan enfermedades cardiovasculares. En respuesta, Medtronic lanzó la campaña 'Carta a mi madre' para fomentar las conversaciones y la conciencia sobre la salud del corazón.
메드트로닉(Medtronic)의 새로운 설문조사에서 여성 심장 건강 인식에 심각한 격차가 드러났습니다. 심혈관 질환이 미국 여성 사망 원인 1위임에도 불구하고, 56%의 여성은 어머니나 가족과 심장 건강에 대해 이야기한 적이 없습니다. 설문조사에 따르면 45%의 여성은 가족 심장병력보다 정치나 돈과 같은 민감한 주제를 먼저 이야기하는 경향이 있었습니다. 특히 94%의 여성이 가족 건강 결정에 책임이 있지만, 60%는 자신의 건강을 우선시하는 데 어려움을 겪고 있습니다. 여성은 심장 질환 치료에서 큰 격차를 경험하며, 남성에 비해 심장 판막 기능 부전 치료를 위한 최소 침습적 치료를 받을 확률이 35% 낮습니다. 유색인종 여성에게는 특히 심각한 영향이 나타나는데, 히스패닉 여성의 43%, 흑인 여성의 59%가 심혈관 질환을 겪고 있습니다. 이에 메드트로닉은 심장 건강 대화와 인식을 촉진하기 위해 '어머니께 보내는 편지' 캠페인을 시작했습니다.
Une nouvelle enquête de Medtronic révèle des lacunes préoccupantes dans la sensibilisation des femmes à la santé cardiaque. Bien que les maladies cardiovasculaires soient la première cause de mortalité chez les femmes aux États-Unis, 56 % des femmes n'ont jamais discuté de la santé du cœur avec leur mère ou d'autres membres de la famille. L'enquête a montré que 45 % des femmes sont plus susceptibles d'aborder des sujets sensibles comme la politique ou l'argent avant l'historique familial de santé cardiaque. Il est notable que 94 % des femmes prennent les décisions de santé au sein de la famille, mais que 60 % ont du mal à prioriser leur propre santé. Les femmes font face à d'importantes disparités dans le traitement des maladies cardiaques, étant 35 % moins susceptibles de recevoir des solutions peu invasives pour une insuffisance valvulaire cardiaque par rapport aux hommes. L'impact est particulièrement sévère chez les femmes de couleur, avec 43 % des femmes hispaniques et 59 % des femmes noires touchées par des maladies cardiovasculaires. En réponse, Medtronic a lancé la campagne 'Lettre à ma mère' pour encourager les conversations et la sensibilisation à la santé cardiaque.
Eine neue Umfrage von Medtronic zeigt besorgniserregende Lücken im Bewusstsein für die Herzgesundheit von Frauen auf. Obwohl Herz-Kreislauf-Erkrankungen die häufigste Todesursache bei Frauen in den USA sind, haben 56 % der Frauen nie mit ihren Müttern oder Familienmitgliedern über Herzgesundheit gesprochen. Die Umfrage ergab, dass 45 % der Frauen eher sensible Themen wie Politik oder Geld besprechen als die familiäre Herzkrankheitsgeschichte. Bemerkenswert ist, dass 94 % der Frauen für Gesundheitsentscheidungen in der Familie verantwortlich sind, aber 60 % Schwierigkeiten haben, ihre eigene Gesundheit zu priorisieren. Frauen erleben erhebliche Ungleichheiten bei der Behandlung von Herzkrankheiten und erhalten 35 % seltener minimalinvasive Lösungen bei Herzklappenfehlern im Vergleich zu Männern. Besonders schwer betroffen sind Frauen mit Migrationshintergrund, wobei 43 % der hispanischen und 59 % der schwarzen Frauen an Herz-Kreislauf-Erkrankungen leiden. Als Reaktion hat Medtronic die Kampagne 'Brief an meine Mutter' gestartet, um Gespräche über Herzgesundheit und Bewusstsein zu fördern.
Positive
  • Campaign aims to increase awareness and encourage vital conversations about women's heart health
  • Medtronic is making donations for every pledge taken to advance women's heart health
  • Initiative addresses a critical healthcare gap, as cardiovascular disease is the leading cause of death in women
Negative
  • 56% of women have never discussed heart health with their mothers or family members
  • Women are 35% less likely to receive proven treatments for heart valve failure compared to men
  • Only 35% of women with family history of heart disease consulted their doctor about heart risk
  • 60% of women struggle to prioritize their own health despite being responsible for family health decisions

Star Jones, award winning television personality & women's heart health advocate, helps kick off heart health conversations this Mother's Day with the Medtronic 'Letter to My Mother' campaign

GALWAY, Ireland, May 7, 2025 /PRNewswire/ -- A new Medtronic-sponsored survey of women ages 30-50 reveals a significant gap in awareness and discussion around heart health among women and their mother-figures. Despite cardiovascular disease being the #1 killer of women in the U.S., many women are still unaware of the risk and the importance of heart health.

The survey, endorsed by WomenHeart and conducted by Wakefield Research, found that nearly half of women (45%) were more likely to discuss sensitive topics such as politics, money, or relationships with their mother or grandmother before discussing family heart health history, despite the fact that as much as half of the risk for heart disease is hereditary.

For more than a century, heart disease has remained the leading cause of death in women, accounting for more deaths than all cancers combined. Yet, when it comes to serious heart concerns, women are up to 35% less likely to be treated with proven, minimally invasive solutions for heart valve failure than men, and women account for more than half (52%) of deaths caused by high blood pressure.1 Additionally, women often experience heart attack symptoms differently, and heart disease disproportionately impacts women of color, with 43% of Hispanic women and 59% of Black women experiencing some form of cardiovascular disease.

The Medtronic Letter to My Mother campaign encourages women to make heart health a priority, starting with a conversation with their mother, or a woman in their life, about family history, risk factors, and the signs and symptoms of heart disease. The campaign, part of the company's ongoing commitment to leading and advancing clinical research for women's health, seeks to close the gap in awareness of heart disease and risks—particularly heart valve failure and high blood pressure—in women.

"The U.S. is at a tipping point when it comes to women's health, and heart health remains the deadliest concern of all," said Nina Goodheart, senior vice president and president, Structural Heart & Aortic, which is part of the Cardiovascular Portfolio at Medtronic. "At Medtronic, we're working relentlessly to ensure women receive personalized, evidence-based healthcare solutions, tailored to them. The launch of Letter to My Mother marks another step in our sustained commitment to improving health outcomes for all."

Results from the survey reveal a surprising disconnect between what women fear for their mothers or mother-figures as they age and the actual conversations happening around family health history:

  • More than half of women (53%) worry that as their mothers age, they will ignore symptoms or fail to inform them when something is wrong.
  • Yet, over half (56%) admit they have never discussed heart health with their mothers or other women in their family.
  • For those with a family history of heart disease, only one-third (35%) asked their doctor to assess their heart risk.  
  • Only 44% of these same women actually talked about it with their mothers or mother-figures.

"As women, we are our own best advocates, but without the confidence, knowledge, or resources to discuss our health history, we are missing out on potential life-saving conversations," said Star Jones, attorney, award-winning television personality & longtime women's heart health advocate. "I come from a family with a long history of heart disease, yet this was rarely a topic we talked about. If only I had acknowledged my risk for heart disease earlier, I could've potentially addressed my concerns with my cardiologist sooner before it led to needing open-heart surgery. That is why I am speaking out now to get all women talking about this disease and how addressing symptoms could save their life – like it did for me."

The survey also revealed that personal heart health is often overlooked by women in the sandwich generation, the population of women who bear the weight of making healthcare decisions for their children, parents, and family members. Almost all (94%) of women surveyed are responsible for making health-related decisions for loved ones, but over 60% of women find it hard to make their own health a priority. 

"As physicians, we know heart health is not one size fits all. Women have a unique experience with heart disease and risk factors - like high blood pressure during pregnancy which may be the first sign of chronic high blood pressure persisting throughout their lifespan," said Dr. Raven Voora, hypertension specialist and nephrologist at UNC Health. "Too often, I've seen women present with risk factors or early signs of heart disease that they put on the backburner behind care for children and loved ones - or these signs and symptoms get brushed off as stress or anxiety. This survey shows us that patients need increased awareness and discussion surrounding heart health and to make sure they pay attention to their heart health."

This May, during Women's Health Month and timed to Mother's Day – Medtronic encourages people to take the pledge to talk to their mother or the women in their life about heart health today. For every pledge, Medtronic will make a donation to a cause that advances women's heart health.

Visit Alettertomymother.com to take the pledge and learn more.

About the Medtronic Letter to My Mother Survey:
Medtronic engaged Wakefield Research to conduct a nationally representative survey to gain insights into consumer perceptions and awareness of heart disease in women aged 30 through 50, targeted to the "daughters" who are sandwiched between taking care of their health, their children and parents. The survey was deployed among 1,000 U.S. women, ages 30 to 50, with a living mother and a living child, between March 13th and March 17th, 2025, using an email invitation and an online survey.

Survey results are endorsed by WomenHeart: The National Coalition for Women with Heart Disease, the nation's leading voice for women living with or at risk of heart disease. WomenHeart is dedicated to promoting awareness, advocacy, and support for women with heart disease, empowering them to take charge of their heart health and improve outcomes.

About the Medtronic Letter to My Mother Campaign:
The Medtronic "Letter to My Mother" campaign aims to educate and close the gap in awareness of heart disease in women — the number one cause of death for more than a century. The campaign encourages people to start conversations with their mothers and loved ones about heart disease, including high blood pressure and heart valve failure, to better understand their family health history and risk factors. The campaign is part of the company's ongoing commitment to leading and advancing clinical research for women's health and was supported by the Medtronic Coronary & Renal Denervation and Structural Heart & Aortic businesses. To learn more about heart disease including signs, symptoms, treatment options and resources to start the conversation today, visit ALettertomyMother.com.

About Medtronic
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic (NYSE:MDT), visit www.Medtronic.com and follow Medtronic on LinkedIn.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

Contacts:

Kimberly Powell
Public Relations
+1-202-498-2601

Ryan Weispfenning
Investor Relations
+1-763-505-4626

1 Caoimhe T Rice, Sophie Barnett, Shea P O'Connell, Enoch Akowuah, Clare E Appleby, John B Chambers, Benoy N Shah, Daniel J Blackman - Impact of gender, ethnicity and social deprivation on access to surgical or transcatheter aortic valve replacement in aortic stenosis: a retrospective database study in England: Open Heart 2023;10:e002373.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/new-survey-1-in-3-women-have-not-talked-to-their-doctor-about-heart-health-the-1-killer-of-women-302448627.html

SOURCE Medtronic plc

FAQ

What are the key findings of Medtronic's 2025 women's heart health survey?

The survey found that 56% of women never discussed heart health with family, 45% prioritize discussing other topics over heart health, and 94% make health decisions for others while 60% struggle to prioritize their own health. Women are also 35% less likely to receive minimally invasive heart treatments compared to men.

How does heart disease affect women of color differently according to MDT's research?

According to the survey, heart disease disproportionately impacts women of color, with 43% of Hispanic women and 59% of Black women experiencing some form of cardiovascular disease.

What is Medtronic's Letter to My Mother campaign?

The Letter to My Mother campaign is an initiative encouraging women to discuss heart health with their mothers or female relatives, focusing on family history, risk factors, and heart disease symptoms. Medtronic will make donations to women's heart health causes for every pledge taken.

Why are women less likely to receive heart valve treatment than men?

The survey reveals women are up to 35% less likely to be treated with proven, minimally invasive solutions for heart valve failure compared to men, and they account for 52% of deaths caused by high blood pressure.

What percentage of heart disease risk is hereditary according to the Medtronic survey?

According to the survey, up to 50% of the risk for heart disease is hereditary, making family history discussions crucial for prevention and early detection.
Medtronic

NYSE:MDT

MDT Rankings

MDT Latest News

MDT Stock Data

108.50B
1.28B
0.26%
86.22%
1.05%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
Ireland
GALWAY